Bruker BioSciences’ stock reached a new 52-week high of $12.24 this week after the firm announced that it would acquire affiliated company Bruker BioSpin for $914 million (see related article, this issue). Bruker’s shares rose 38.2 percent for the five-day trading week ended Tuesday to lead all gainers in the BCW Index.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.